IL10 and metabolic dysfunction-associated steatohepatitis: Therefore, in our study, it is reasonable to find that the OCA-treatment-related upregulation of IL-10 and inhibition of IL-1β suppressed cardiac apoptotic activity and increased FS in the NASH mice.